Table 2.

Characterization of Cultured CD34+ Cells Infused to Transplant Recipients and of HDCT

Patient No.Cells Seeded on Day 0 (total CD34+ cells ×104/kg)Cells Infused After 7 Days of CultureHDCT
Total CD61+ Cells (×105/kg)% ViableCFU-mega (×104/kg)CFU-GM (×104/kg)CFU-GEMM (×104/kg)
2.2 1.0 82 1.8 2.8 0.1 Mitox, L-PAM 
3.2 1.5 85 2.3 3.2 0.2 Mitox, L-PAM 
2.8 1.2 79 2.3 3.9 0.2 Thiotepa, L-PAM 
3.3 1.2 86 2.1 3.1 0.3 Thiotepa, L-PAM 
3.0 1.0 86 2.7 3.0 0.2 Thiotepa, L-PAM 
2.5 1.1 94 2.6 2.9 0.2 Thiotepa, L-PAM 
6.1 2.5 75 4.9 7.5 0.5 Thiotepa, L-PAM 
12.2 5.2 89 11.0 14.6 1.1 Thiotepa, L-PAM 
23.0 9.8 92 23.7 27.6 1.6 Thiotepa, L-PAM 
10 52.7 21.3 87 38.2 60.3 4.1 Thiotepa, L-PAM 
Patient No.Cells Seeded on Day 0 (total CD34+ cells ×104/kg)Cells Infused After 7 Days of CultureHDCT
Total CD61+ Cells (×105/kg)% ViableCFU-mega (×104/kg)CFU-GM (×104/kg)CFU-GEMM (×104/kg)
2.2 1.0 82 1.8 2.8 0.1 Mitox, L-PAM 
3.2 1.5 85 2.3 3.2 0.2 Mitox, L-PAM 
2.8 1.2 79 2.3 3.9 0.2 Thiotepa, L-PAM 
3.3 1.2 86 2.1 3.1 0.3 Thiotepa, L-PAM 
3.0 1.0 86 2.7 3.0 0.2 Thiotepa, L-PAM 
2.5 1.1 94 2.6 2.9 0.2 Thiotepa, L-PAM 
6.1 2.5 75 4.9 7.5 0.5 Thiotepa, L-PAM 
12.2 5.2 89 11.0 14.6 1.1 Thiotepa, L-PAM 
23.0 9.8 92 23.7 27.6 1.6 Thiotepa, L-PAM 
10 52.7 21.3 87 38.2 60.3 4.1 Thiotepa, L-PAM 

or Create an Account

Close Modal
Close Modal